Russia's proposed tobacco product regulation and licensing requirements

Apr.14.2023
Russia's proposed tobacco product regulation and licensing requirements
Russia proposes mandatory licenses for tobacco products and raw materials, effective from September 1, 2023.

On April 12th, the "Proposal on State Regulation of the Production and Circulation of Tobacco Products, Tobacco Industry Products, Nicotine-Containing Products and Their Raw Materials" (No. 310882-8, hereinafter referred to as "the Proposal") was passed in the first reading by the State Duma of Russia.


The following are the original text and Chinese translation of the relevant proposal by 2FIRSTS.


Classification of Mandatory Licensing Types


The first section of Article 8 of the proposal stipulates mandatory licensing requirements for the production and sale of tobacco products, nicotine-containing products, and raw materials used to produce such products.


What kinds of tobacco products are specifically covered by the license? Which stages require specific licenses? Is a license required for the import and export of products? Liang Jiasen, a market researcher for 2FIRSTS in Russia, provided a professional interpretation of the proposal.


According to the first part of Article 8 in general terms, activities related to the production and sale of tobacco products, nicotine-containing products, and materials utilized in the production of these products require a license.


The production, storage, and supply of tobacco products, raw materials, nicotine-containing products, and raw materials for the production, storage, and supply of tobacco products and nicotine-containing products are involved in their import and export within the Russian Federation. The circulation of raw materials and nicotine-containing raw materials is also included in their import and export within the Russian Federation. Additionally, the purchase of tobacco products and nicotine-containing products for use as duty-free trade under customs procedures, as well as the production, storage, and supply of cigars and related activities are included.


Experts Interpret


According to Liang Jiasen, a market researcher at 2FIRSTS, the first item on the license refers to a "raw material production license" for the production, storage, and supply of tobacco products, raw materials, nicotine-containing products, and nicotine raw materials. Such a license is required at every stage of the raw material production process.


Regarding the second provision on "production, storage and supply of tobacco products and products containing nicotine," this license is known as a "product manufacturing license," which is required for all stages of production for such products.


In relation to the third point regarding the circulation of tobacco and nicotine-containing products entering and exiting the Russian Federation, the license referred to is the "Product Import License". This license is necessary for the importation of such products into Russia and must be presented at all relevant stages of the process.


In relation to the fourth item on the import and export of raw materials and nicotine raw materials into and out of the Russian Federation, the license required is the "Raw Material Import License", which is necessary for the importation of such products into Russia. This license is required for all relevant import processes in Russia.


Regarding the fifth provision which pertains to the production, storage, and supply of cigars, it is identified as the "Cigar Production License" of the Russian Federation.


Regarding the sixth provision, which pertains to the purchase of tobacco and nicotine-containing products for sale as duty-free goods under customs procedures, this clause is part of the Russian Federation's "License for the Circulation of Duty-Free Tobacco and Nicotine products.


Scheduled to take effect on September 1st, 2023.


If the proposal is ultimately passed through the Russian legislative process, it will come into effect on September 1, 2023, with the mandatory licensing provisions outlined in Section 8, Part 1 of the proposal to be implemented on the same date. Holding a license will become a requirement from March 1, 2024. If tobacco manufacturers are found to not have a license, to have their license suspended or revoked, their production equipment will be ordered to be sealed.


2FIRSTS will continue to interpret and provide further details on laws and related content.


Topic: Progress and Expert Analysis on Russia's Ban on Flavored E-cigarettes (Click the Image Below to Jump)


Expert Analysis Series:


Expert analysis 1: The ban on flavored e-cigarettes in Russia includes all products, and the specific standards for additives have yet to be disclosed.


Expert analysis 2: Russia sets minimum retail price for e-cigarettes to reduce demand for nicotine products.


Further Reading:


Manufacturers of nicotine products in Russia now need to apply for a license following the approval of a draft law during its first reading.


Timeline and Background of Russia's Taste Ban Law Passed in Three Readings in One Day


On September 1st, a ban on flavor additives in e-cigarettes in Russia will take effect. The proposal text is available in reference 3. On April 11th, a proposal to ban flavored e-cigarettes in Russia will undergo its first discussion.


Russia proposes to impose a maximum fine of 500,000 rubles on those who sell electronic cigarettes to minors.


What is the progress in the ban on flavored products in the Russian legislative process?



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU finance ministers failed to reach agreement on tobacco excise reform at the November 9, 2026 Economic and Financial Affairs Council (ECOFIN) meeting in Brussels. The Irish Council presidency's compromise secured support from 26 of the EU's 27 member states, but Malta withheld consent, preventing the Council from reaching a general approach requiring unanimity. The reform would raise minimum taxes on conventional tobacco and bring e-cigarette liquids, heated tobacco and nicotine pouches into a common EU minimum excise framework. Finland and Estonia accepted further concessions during the meeting, while the presidency proposed separating the inclusion of nicotine pouches in the framework from setting their precise minimum tax rates. Another compromise would allow ten qualifying member states until 2036 to meet certain tobacco excise requirements. Ireland intends to continue negotiations in December.
Regulations
Nov.11
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
The U.S. FDA authorized 24 VELO nicotine pouch products from a British American Tobacco subsidiary, raising the total number of authorized products from 43 to 67, a 55.8% increase. The newly authorized 4 mg products include lime and passion fruit flavors and feature certified child-resistant packaging. VELO's first FDA marketing authorization adds BAT to a list previously limited to PMI and Altria products, while bringing the agency's nicotine pouch review pilot total to 47 authorized products.
Oct.30
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16